Brief: Willow Biosciences Anticipates Transitioning Into A Revenue Generating Development Company In 2021
Nov 13 (Reuters) - Willow Biosciences Inc WLLW.TO :
* WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2020 RESULTS AND
OPERATIONAL UPDATE
* ANTICIPATES TRANSITIONING INTO A REVENUE GENERATING
DEVELOPMENT
COMPANY IN 2021
* WILLOW SAYS ENDED QUARTER WITH APPROXIMATELY $9.1 MILLION
IN
CASH ON HAND
* WILLOW BIOSCIENCES - IN COMING MONTHS AND QUARTERS, CO
WILL BE
SELECTING ITS FIRST MANUFACTURING LOCATION AND PARTNER TO START
COMMERCIAL PRODUCTION
Source text for Eikon: ID:nCNWss2Jpa
Further company coverage: WLLW.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atlas Energy
See all newsBrief: Atlas Energy Corp. Announces Appointments To Subsidiary Board And Extension Of Tsxv Sandbox Exit Deadline
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Strengthens Leadership Team With Appointment Of Andy Duncan As Senior Executive
Brief: Willow Biosciences Announces Completion Of Transformative Recapitalization Transactions To Form Atlas Energy Corp